
Three nutritious Korean dishes to beat summer heat
This principle is based on the idea that the body, like a self-regulating ecosystem, works to maintain its internal temperature in extreme conditions. The body expels heat through sweat, which, despite the external heat, leaves the skin feeling cool. However, the body itself may feel cold after such a process. To counterbalance this, Koreans opt for traditional, hot, nourishing dishes that help restore warmth and balance.
Here's a look at three iconic summer dishes, known for their health benefits, that are beloved by locals and visitors alike, along with recommendations for where to experience them in Seoul.
Samgyetang
A quintessential summer dish, samgyetang is a health-boosting soup made by boiling chicken stuffed with ginseng, jujube, chestnut, glutinous rice and garlic. It is traditionally consumed during the peak of the summer heat to build stamina and provide energy for the body. One of Seoul's most famous spots to enjoy samgyetang is Tosokchon, located near Gyeongbokgung in Seochon. With a rich history, Tosokchon is known for its signature samgyetang, which is made from high-quality young chicken and a secret blend of ingredients that creates a rich and creamy broth. The restaurant's ambiance, housed in a traditional Korean hanok, complements the dish's healing properties, providing a serene setting to savor this comforting meal. A serving of samgyetang costs around 20,000 won ($15.00) and comes with a refreshing glass of ginseng liquor to enhance its effects.
The broth of samgyetang is delicately flavored, and the chicken is tender, easily separating from the bones. The dish is not overly seasoned, allowing the natural flavors of the ingredients to shine. Served with a side of seasoned kimchi, it's a perfect meal to restore strength and maintain your internal balance in the summer.
Chueotang
Another traditional Korean summer dish is chueotang, a nutritious and hearty soup made with loach (a small freshwater fish) that has been finely ground and cooked with vegetables such as mushrooms, tofu and radish. Widely regarded as a "stamina food," it is packed with protein, vitamins and minerals. Its mildly spicy and savory broth provides a satisfying meal that is both hearty and refreshing, perfect for replenishing the body's fluids and essential nutrients during peak summer.
A well-known establishment serving this beloved dish is Yonggeumok in Seoul's Jongno district. This restaurant, which has been serving its famous chueotang (15,000 won) for almost a century, maintains traditional methods, offering both a Seoul-style (whole loach) and a Namdo-style (ground loach) version of the soup. The broth, made from the fish and various vegetables, is both robust and clean, with the loach's natural flavors enhanced by a touch of seasoning. The soup is often served with a sprinkle of Chinese pepper, allowing customers to adjust the flavor to their preferences.
Galbitang
For those seeking something heartier, galbitang, a beef short rib soup, is a must-try dish. The soup is made by boiling short ribs with radish until tender, creating a clear and savory broth packed with nutrients. The tenderness of the beef and the clean, refreshing flavor of the broth make galbitang a popular choice for those looking to replenish their strength and cool down during the summer.
A standout restaurant for galbitang is Onsimok, located in Seoul's Gangnam district. The broth is made by simmering beef ribs and radish for hours, resulting in a rich and clear soup. The beef is so tender that it effortlessly separates from the bone, offering a melt-in-your-mouth experience. The addition of minari (water parsley) enhances the flavor, offering a light, herbaceous note that balances the richness of the broth. A bowl of galbitang here costs approximately 17,000 won.
Onsimok is known for its unique take on the dish, incorporating an exclusive spicy seasoning mix made from green chili peppers, which adds a subtle kick to the soup, making it even more invigorating. The restaurant's philosophy is simple yet powerful: "One bowl of galbitang will amaze the world.'
In the sweltering heat of summer, Koreans turn to these traditional dishes not just for their taste, but for their ability to restore balance to the body. Samgyetang, chueotang and galbitang are nourishing elixirs, offering both sustenance and relief from the summer heat. Whether you're looking to revitalize your body, boost your energy or simply enjoy a comforting bowl of soup, these dishes provide an opportunity to experience the best of Korean cuisine this summer.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Korea Herald
4 days ago
- Korea Herald
Korea urges measles vaccination before overseas travel as imported cases rise
Amid a sharp rise in imported cases of measles recently, the Korea Disease Control and Prevention Agency has urged travelers to ensure they are fully vaccinated against the infectious disease before going abroad. According to KDCA data released Wednesday, 68 cases of measles had been confirmed in Korea as of Aug. 9, since the government began to closely observe outbreak cases in December 2024. The number of cases observed most recently was a 1.4-fold increase from the number of cases recorded over the same period a year prior. Of the total number of cases, 49 — 72.1 percent — were infections contracted overseas and detected after entry. A majority of the cases, adding up to 42 in total, were found to be contracted from Vietnam, followed by South Africa, Uzbekistan, Thailand, Italy and Mongolia. The nineteen other domestic cases were also linked to these imported infections, with transmission occurring in households and medical facilities with measles patients. Adults made up a majority of the cases, with 77.9 percent of patients aged 19 or older. Notably, 54.4 percent were either unvaccinated against measles or were unsure of their vaccination status. Citing data from the World Health Organization, the KDCA said some 360,000 measles cases were reported globally in 2024, with outbreaks still continuing to be observed into this year in Europe, the Middle East, Africa and Southeast Asia — regions all frequented by Korean travelers. According to the agency, lower vaccination rates for measles worldwide have fueled the resurgence. Due to the COVID-19 pandemic, measles vaccinations were disrupted due to a strain in the health care system as well as lockdowns that made it difficult for some families to access vaccination services. In 2023, the global rate of the second-dose measles vaccination — which is crucial for full immunity — was 74 percent, below the WHO-recommended 95 percent. To stay safe from measles infections, the KDCA has advised travelers to measles-affected countries to complete the two-dose measles, mumps and rubella vaccine. Those developing a fever or a rash within three weeks of returning to South Korea from a measles-affected country should wear a mask, minimize contact with others and inform medical authorities of recent travel before seeking care. Extra caution is urged for households with infants too young for vaccination, pregnant women and those with weakened immune systems.


Korea Herald
4 days ago
- Korea Herald
HLB appoints Brian Kim as CEO of US subsidary Elevar Therapeutics
Korean biopharmaceutical firm HLB said Wednesday it has appointed Brian Kim, current CEO of HLB Innovation and Verismo Therapeutics, as CEO of its US subsidiary, Elevar Therapeutics. Kim will lead all three companies concurrently. HLB said the leadership change is a strategic move to align with the skills needed at each stage of drug development, particularly as Elevar prepares to enter the commercialization phase and expand global partnerships with big pharma. Kim holds extensive experience in finance, strategic business management and biotechnology, including research in CAR-T cancer treatments and founding multiple biotech firms. A former tenured clinical professor at the University of Pennsylvania School of Dental Medicine, Kim was a founding member of Nasdaq-listed Inovio Pharmaceuticals. He has invested in various businesses, including acquiring a Kospi-listed company and elevating it into the Kospi 200 index. Kim also has invested in and led several biotech ventures in both the US and Korea. 'I feel a deep sense of responsibility taking on this role at such a pivotal moment,' Kim said. 'My focus will be on securing regulatory approval for Elevar's lead liver cancer therapy and ensuring its successful commercialization, while driving sustainable growth for the company.' HLB added that Kim's leadership will help accelerate Elevar's global business expansion and innovation in oncology therapeutics.


Korea Herald
5 days ago
- Korea Herald
Celltrion expands presence in Italy with autoimmune, anticancer drugs
Korean biopharma scores seven contracts in first half of 2025 in major European market Celltrion has won bids to supply its autoimmune drug Steqeyma in seven states in Italy in the first half of this year to expand its presence in the country, the Korean biopharmaceutical company said Tuesday. According to Celltrion, it recently won the bids for autoimmune medicine in Veneto, Trentino-Alto Adige and Sardinia. The drug maker said it plans to supply Steqeyma to these regions through May. Celltrion pointed out that the drug rapidly secured contracts after launching in Italy in January. Remsima, Celltrion's flagship autoimmune drug, also continues to secure orders in Italy as it won a bid in the state of Umbria, while Remsima SC was able to renew a contract with Puglia. According to Celltrion, Remsima SC is being sold in all 20 states in Italy. Medicine market analyst IQVIA estimates that Remsima and Remsima SC combined for 66 percent of the Italian autoimmune drug market in the first quarter. Celltrion's anticancer drugs Truxima and Vegzelma won the bids in the states of Lazio and Umbria, respectively, earlier in the year, taking up 29 percent and 30 percent of the market. The company said it expects to keep supplying anticancer drugs in Italy as more bids are scheduled in the second half of the year. 'Based on high trust from major stakeholders in Italy's medical industry, a key pharmaceutical market in Europe, Celltrion's autoimmune treatments and anticancer drugs are expanding influence by logging a series of orders,' said Yoo Won-sik, general manager of Celltrion's Italian office. 'We will continue to launch new products and score more orders in the second half to expand the prescription of our products and keep up the growth of performance.'